Blumhouse just handed a $400 million smoking crater to the one director they’re betting can perform an actual exorcism on their cursed franchise. Mike Flanagan‘s The Exorcist: Martyrs starts shooting February 23 with Scarlett Johansson playing—and I’m not making this up—a “rookie detective” in a small town facing “inconceivable darkness.” Because nothing says fresh creative vision like casting Black Widow as a cop fighting demons.
- The $400 Million Hole That David Gordon Green Dug
- Why Johansson Signals Desperation, Not Innovation
- The Flanagan Factor: Total Creative Freedom (With Asterisks)
- What “Inconceivable Darkness” Actually Signals
- Seven Films Deep in a Franchise Nobody Asked to Resurrect
- What The Exorcist: Martyrs Signals About Horror’s Future
- FAQ
- Why is Blumhouse still making Exorcist movies after David Gordon Green’s disaster?
- Does Scarlett Johansson’s casting change what kind of horror film this will be?
- Will Mike Flanagan’s Exorcist connect to the original 1973 film?
- Why did Universal pull The Exorcist: Martyrs from its March 2026 release date?
- Can Mike Flanagan actually save the Exorcist franchise with this reboot?
Here’s what’s actually happening: Universal is in full damage control mode. After David Gordon Green turned their prestige horror investment into a 22% Rotten Tomatoes punchline that barely crossed $136 million globally, they’ve pivoted to the safest bet in modern horror. Flanagan is Netflix’s horror golden boy, the guy who made The Haunting of Hill House feel like arthouse television and turned Midnight Mass into appointment streaming. More importantly, he’s never made a true financial disaster—even his theatrical misses like Doctor Sleep gained cult redemption on streaming.
The $400 Million Hole That David Gordon Green Dug
Let me paint you the financial horror story Universal executives see when they close their eyes. They paid $400 million—not a typo—for the Exorcist rights, betting that nostalgia for the 1973 classic would translate to Marvel-level returns. David Gordon Green, fresh off his Halloween trilogy, seemed like the perfect architect.
Then Exorcist: Believer happened.
Not just bad—which would be forgivable—but boring, which isn’t. A “C” CinemaScore. That’s audiences actively disliking sitting through this thing. Green, to his credit, read the room and bailed. Announced he was done with the franchise and signed onto indies instead. Smart move for him. But that left Universal with two contracted films and a brand that now carried the stench of failure.
Enter Flanagan with what production listings confirm as The Exorcist: Martyrs—a title that already tells you everything about the studio’s emotional state. They’re the martyrs here, throwing themselves on the sword of their own bad investment.
Why Johansson Signals Desperation, Not Innovation
Casting Scarlett Johansson as a small-town rookie detective isn’t creative; it’s insurance. This is Universal’s way of guaranteeing international pre-sales and streaming algorithm friendliness. Johansson’s name alone adds $20-30 million to any film’s global floor—that’s just math.
But here’s what bugs me: it fundamentally misunderstands what made the original Exorcist work.
William Friedkin cast unknowns and character actors. Ellen Burstyn wasn’t a megastar. Linda Blair was a nobody. Max von Sydow had gravitas but not marquee value. The film’s power came from feeling real, grounded, possible. You put ScarJo in your demon movie, and suddenly I’m watching Black Widow fight CGI darkness, not a mother trying to save her daughter’s soul.
I’ve seen this playbook before. Remember when they cast Russell Crowe in The Mummy reboot to launch Dark Universe? Or when Will Smith headlined After Earth to guarantee Shyamalan’s comeback? Star power doesn’t fix fundamental franchise fatigue. It just makes the failure more expensive.
The Flanagan Factor: Total Creative Freedom (With Asterisks)
Here’s where it gets interesting though. Flanagan reportedly got “total creative freedom”—which in Hollywood means “do whatever you want as long as it’s commercially viable.” But Flanagan’s smart. Notice how the synopsis mentions zero connection to previous installments? He’s not making Exorcist 7; he’s making a Mike Flanagan horror film that happens to have the Exorcist brand slapped on it.
That pale blue-gray color grading he loves, the slow-burn family drama masquerading as horror, the monologues about faith and doubt—we’re getting all of it, just with better marketing.
The “Martyrs” subtitle isn’t about religious sacrifice; it’s about Flanagan martyring himself to save Universal’s investment while maintaining his auteur credentials. And honestly? That might be the only play that works.
Universal quietly pulled the original March 2026 date earlier this summer. No new date set. That’s not scheduling conflict—that’s giving Flanagan room to actually make something decent instead of rushing to meet a fiscal quarter deadline. They learned that lesson from Believer, at least.
What “Inconceivable Darkness” Actually Signals
That synopsis language—”inconceivable darkness”—is pure studio speak for “we’re still figuring this out.” It’s the horror equivalent of “a journey of self-discovery.”
But paired with “rookie detective,” I can already see the pitch: True Detective meets The Exorcist. Atmospheric dread, investigative procedure, probably a conspiracy involving the church, definitely a third-act revelation that the real demon was institutional corruption all along. It’s Flanagan’s wheelhouse dressed up as franchise revival.
Which… might work. Not because audiences want another Exorcist film—they demonstrably don’t—but because they want another Mike Flanagan joint. The Exorcist branding just gets it on more screens.
Seven Films Deep in a Franchise Nobody Asked to Resurrect
The Exorcist franchise has now grown to seven films with Flanagan’s entry. Only the original and maybe Exorcist III deserve to exist. The rest are varying degrees of “why?” But here’s the thing about the horror business: IP is forever. That $400 million Universal spent? They’ll mine this franchise until it’s dust, then remake the dust.
Flanagan’s version will probably be good. Maybe even very good. He doesn’t make bad horror films; he makes horror films that film Twitter argues about for months.
But good doesn’t equal necessary.
This feels like watching a master chef work at McDonald’s—sure, that Quarter Pounder might taste better, but it’s still a Quarter Pounder. The real test comes when this hits theaters without a release date. Will audiences show up for Flanagan’s name? Will Johansson’s star power translate to horror audiences? Or will this be another respectable failure that Universal points to while explaining why they’re $400 million in the hole?
My bet: The Exorcist: Martyrs will be the best Exorcist sequel nobody asked for. It’ll get decent reviews, make enough money to justify the second film in Flanagan’s two-picture contract, and then quietly disappear into the streaming void where it’ll find its actual audience—Flanagan completists who would’ve watched it regardless of the title.
But hey, at least it won’t be boring. That’s already an improvement over Believer. Sometimes not being terrible counts as a win in this industry.
Blumhouse owes Universal two Exorcist films. Flanagan’s signed for both. The clock’s ticking on that $400 million investment, and everyone involved knows it. Whether Johansson’s star power and Flanagan’s craft can actually save this franchise—or just make its death more dignified—is the question worth watching. Either way, someone’s getting exorcised here. Probably the executives who signed that original check.
What The Exorcist: Martyrs Signals About Horror’s Future
- Star Insurance Over Story: Johansson’s casting proves Universal learned the wrong lesson from Believer’s failure—throw money, not ideas
- Auteur as Band-Aid: Flanagan’s reputation is being weaponized to rehabilitate damaged IP, not create new stories
- The Franchise Trap: Seven films deep, even total creative freedom can’t escape brand expectations
- Streaming Safety Net: This film’s real afterlife begins on Peacock, not in theaters
- Two-Picture Pressure: Flanagan must deliver enough success to justify film two—failure isn’t an option for anyone
FAQ
Why is Blumhouse still making Exorcist movies after David Gordon Green’s disaster?
Contractual obligation plus sunk cost psychology. They owe Universal two more films and need to justify that $400 million rights purchase to shareholders. Walking away means admitting complete failure. Flanagan’s involvement lets them claim “creative overhaul” even if nobody’s asking for this.
Does Scarlett Johansson’s casting change what kind of horror film this will be?
“Rookie detective” suggests procedural elements—think Seven meets possession horror. Johansson’s action credibility helps sell the physical confrontation scenes modern audiences expect, but it also risks making this feel more like a thriller than the slow‑burn dread Flanagan typically delivers.
Will Mike Flanagan’s Exorcist connect to the original 1973 film?
The synopsis explicitly claims “no connection to previous installments.” Flanagan’s doing what he did with Doctor Sleep—making his own film that happens to exist in a famous universe. Expect reverence through tone, not direct narrative links. It’s brand exploitation disguised as fresh vision.
Why did Universal pull The Exorcist: Martyrs from its March 2026 release date?
Reading between the lines: they saw early development and realized rushing Flanagan would repeat the Believer disaster. No new date is set. Better to give him time and hope quality translates to returns than meet an arbitrary deadline with mediocrity.
Can Mike Flanagan actually save the Exorcist franchise with this reboot?
Define “save.” Make a good film? Probably—he hasn’t made a bad one yet. Recover $400 million in franchise value? Almost certainly not. The best‑case scenario is a respectable performer that keeps the IP warm for future exploitation. Sometimes that’s all a franchise resurrection can hope for.
